zzzs
Pathology

Department: Pathology

G

  • Academic Appointments Associate Professor - Med Center Line,  Pathology
    Clinical Focus
    • Pathology and Laboratory Medicine
    • Pediatric Hematology-Oncology
    Research Interest

    Enhancement of transfusion safety and effectiveness, with a focus on quality assurance in transfusion therapy; transfusion medicine education; pediatric and adult transfusion therapy

  • Academic Appointments Professor,  Pathology
    Member,  Bio-X
    Member,  Stanford Cancer Institute
    Professor,  Microbiology & Immunology
    Clinical Focus
    • Pathology
    • Pathology and Laboratory Medicine
    Research Interest

    The goals of Dr. Galli's laboratory are to understand the regulation of mast cell and basophil development and the expression of mast cell and basophil function, and to develop and use genetic approaches to elucidate the roles of these cells in health and disease.

  • Academic Appointments Associate Professor - Med Center Line,  Pathology
    Clinical Focus
    • Pathology and Laboratory Medicine
    • Pediatric Pathology
    Research Interest

    Pediatric Hematopathology, Pediatric Laboratory Medicine and Pathology

  • Academic Appointments Professor,  Pediatrics - Hematology & Oncology
    Professor (By courtesy),  Pathology
    Clinical Focus
    • Pediatric Hematology-Oncology
    Research Interest

    Hematology/Oncology, biology, and treatment of bone marrow failure disorders, hereditary coagulation disorders-clinical trials.

  • Academic Appointments Clinical Assistant Professor,  Pathology
    Clinical Focus
    • Anatomic/Clinical Pathology
    • Transfusion Medicine
  • Academic Appointments Professor - Med Center Line,  Pathology
    Professor - Med Center Line,  Medicine - Hematology
    Clinical Focus
    • Pathology
    Research Interest

    Dr. Goodnough has a long-standing interest in alternatives to blood therapy. This includes the concept of antologous blood predonation before elective surgery; acute normovolemic hermodicution;erythropoietic agents to stimulate red blood cell production; pharmacologic strategies to reduce blood loss; artificial oxygen carriers; and re-evaluation of the transfusion trigger. Publications: Goodnough LT: "Erythropoietin", In Scientific Basis of Transfusion Medicine..

  • Academic Appointments Assistant Professor,  Pathology
    Member,  Bio-X
    Research Interest

    We are interested in addressing questions in neuronal development and function by a combination of genetic, cell biological, biochemical and chemical approaches. The main focus of our lab is centered around two topics: 1) the interface of signaling and gene regulation in neuronal development, with a focus on calcineurin-NFAT signaling; 2) the development of small molecules, which interfere with protein-protein interactions underlying neurodegenerative diseases.

  • Academic Appointments Assistant Professor - Med Center Line,  Pathology
    Member,  Stanford Cancer Institute
    Clinical Focus
    • Pathology
    • Anatomic/Clinical Pathology
    Research Interest

    I have two major research interests: the pre-leukemic bone marrow failure disorder myelodysplastic syndrome, or MDS; and the role of vascular endothelial growth factor (VEGFR) signaling in lymphoma. I have developed a novel protocol to quantitate protein expression in a cell-lineage-specific pattern in intact bone marrow using a combination of multiple immunofluorescence on tissue microarrays, semi-automated high resolution image scanning, and sophisticated image analysis.

  • Academic Appointments Emeritus Faculty, Acad Council,  Pathology
    Clinical Focus
    • Pathology
    • Pathology and Laboratory Medicine
    Research Interest

    Work in our laboratory is focused on the study of the human major histocompatibility (HLA) complex. We are seeking to characterize the genes and gene products of this complex and to understand their role in determining transplantation and transfusion compatibility. Laboratory work on this topic ranges from clinical studies correlating graft rejection with HLA antigens identified by classical serology or DNA typing.

Stanford Medicine Resources:

Footer Links: